Moving blood between the heart and lungs, pulmonary circulation is a crucial function in the body. Elements of the pulmonary system include your heart, lungs, veins, and arteries.
According to the National Institutes of Health (NIH), congestive heart failure, or the inability of heart muscle cells to pump blood efficiently, is a relatively common condition. It afflicts more than four million people in the U.S., with approximately 400,000 new cases per year.As the leading cause of death among men and women in the North America, heart disease is a damaging and deadly foe.
Stem Cell Therapy in New York, Toronto and Montreal
Our medical practice participates in investigational studieswith local patients from New York, and from cities abroad such as Montreal and Toronto to evaluate the effectiveness of adipose stem cells for asthma treatment, heart failure, and cardiomyopathy within a number of conditions that effect cardiac and pulmonary health. Adipose stem cells are harvested in a mini-liposuction process from your own fat cells to treat these various conditions.
Exploration of Stem Cells for Treatment of Cardiac and Pulmonary Conditions
We aim to advance the knowledge base and practice of regenerative medicineby contributing data through patient-funded investigation into treatment areas that include:
Asthma: Characterized by symptoms that include chest tightness, wheezing, and shortness of breath, asthma affects an estimated 300 million people worldwide, and contributes to over 200,000 deaths per year. Investigational procedures are ongoing to use adult-derived stem cells to influence reactive airways associated with asthma, making stem cells for asthma treatment a viable option.
Post Myocardial Infarction (MI): MI is the term used to describe a heart attack, or a sudden loss of heart function. The American Heart Association notes more than 400,000 out-of-hospital cardiac arrests occur each year. During a heart attack, cells in the heart muscle are damaged by loss of blood supply, usually caused by a blockage. After a heart attack, a priority goal of investigative regenerative medicine is to assist the healing of damaged heart muscle cells through the deployment of stem cells.
Congestive Heart Failure (CHF) and Cardiomyopathy: Heart failure occurs due to weakening of the heart, or other factors like infection, causing it to lose its ability to effectively pump blood. Chronic disease or weakening of the heart is called cardiomyopathy. Stem cell deployment -- intravenously, by injection, and by placement in coronary arteries -- is being studied as a promising treatment for helping the heart heal itself.
Lung disease: Chronic Obstructive Pulmonary Disease (COPD) is a condition that makes it hard for you to breathe. According to the National Institutes of Health (NIH), the two leading forms of COPD include emphysema and chronic bronchitis. Both emphysema and chronic bronchitis cause damage to lung cell function over time. At present, studies are being conducted to evaluate the use of adult stem cells to improve lung elasticity, and reduce lung damage suffered by patients with COPD.
In discussing use of stem cells to treat damaged cardiac tissue, one NIH study notes “Stem cells may well serve as the foundation upon which a future form of ‘cellular therapy’ is constructed.”
If you have questions about stem cell deployment for cardiopulmonary disease, please contact us at the New York Stem Cell Treatment Center at (212) 262-2412.
Note: We provide stem cell therapies for patients from all over the U.S including New York areas like Manhattan, Brooklyn, Queens, the Bronx, Staten Island, Nassau County, Suffolk County, Long Island, and Westchester, New Jersey, Connecticut, Pennsylvania. We also work withCanadian patientsfromcities such as Montreal and Toronto.